Filing Details

Accession Number:
0001209191-20-048226
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-25 16:34:19
Reporting Period:
2020-08-21
Accepted Time:
2020-08-25 16:34:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1802665 Harmony Biosciences Holdings Inc. HRMY () G7
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1388325 A/S Holdings Novo Tuborg Havnevej 19
Hellerup G7 2900
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-21 4,277,300 $0.00 4,277,300 No 4 C Direct
Common Stock Acquisiton 2020-08-21 132,503 $24.00 4,409,803 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2020-08-21 25,000,000 $0.00 4,026,784 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2020-08-21 1,860,107 $0.00 250,516 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. The Series A Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted on a 8.215-for-1 basis into the number of shares of Common Stock as shown in Column 7 upon the closing of the Issuer's initial public offering without payment or further consideration. The number of shares of Common Stock shown in Column 7 also includes the payment of an accrued stock dividend by the Company to the holder which became due and issuable upon the conversion of the convertible preferred stock. These shares have no expiration date.
  2. Represents a purchase from the underwriters in the Issuer's initial public offering.